Delivery Order SPE2DB24D3015-SPE2DB25FFZRY
- Not listed
- The Defense Logistics Agency awarded a $2,965.10 delivery order to AmerisourceBergen Drug Corp on April 25, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 grams). This competitively awarded, firm fixed-price delivery order is scheduled for completion by April 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed openly among qualified vendors. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Advair HFA 230-21 mcg inhalers (12 gm units) on July 10, 2025, with a ceiling value of $1,397.07 and an ultimate completion date of July 11, 2025. This contract is a firm fixed-price delivery order with no set-aside designation, issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Advair HFA 115-21 mcg inhalers (12 grams) with a contract value of $3,313.05. This competitively awarded, non-set-aside delivery order is classified as firm fixed price and is scheduled for completion by September 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Advair HFA 115-21 microgram inhalers (12 gram units) with a ceiling value of $1,476.11. This is a firm fixed price delivery order with an ultimate completion date of August 1, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $3,608.85 to AmerisourceBergen Drug Corp for the supply of Advair HFA 230-21 microgram inhalers (12 grams) on May 30, 2025, with an ultimate completion date of June 2, 2025. This contract is structured as a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,775.70 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm) on May 8, 2025, with an ultimate completion date of May 9, 2025. This firm fixed-price delivery order represents a non-competitive award and will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC)...
- The Defense Logistics Agency awarded a $2,646.36 delivery order to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm), with an ultimate completion date of June 13, 2025. This competitive award—utilizing firm fixed pricing with no set-aside designation—represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Advair HFA 230-21 mcg inhaler 12gm pharmaceutical products, valued at $3,070.68 with a completion date of June 20, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is the company's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $5,586.85 to AmerisourceBergen Drug Corp for the supply of Advair HFA 230-21 microgram inhalers (12-gram units). This firm fixed price delivery order, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded a $3,092.18 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Advair HFA 115-21 microgram inhalers (12 grams) with a completion date of September 15, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award through open solicitation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB25FFZRYDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,745.46 to AmerisourceBergen Drug Corp on June 6, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gram units). This is a firm fixed-price, non-set-aside delivery order with a completion date of June 9, 2025, to be performed at the contractor's location in Conshohocken, Pennsylvania. As a delivery order, this award falls under a larger indefinite delivery contract (IDC) vehicle—specifically AmerisourceBergen's $999.999 billion DLA Troop Support Medical prime contract (SPE2DX) that runs through December 2026, which enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive portfolio with the DLA demonstrates capability across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This delivery order reflects the company's role in the broader DLA Pharmaceutical Prime Vendor Global Program, which supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles designed to ensure reliable access to essential medications across the military health system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 6/6/25 |